| The challenges of new drugs benefits and risks analysis: lessons from theximelagatran FDA Cardiovascular Advisory Committee. | Contemp Clin Trials | 2006 Oct | 16769255 |
| Treatment of natto, a fermented soybean preparation, to prevent excessive plasma vitamin K concentrations in patients taking warfarin. | J Nutr Sci Vitaminol (Tokyo) | 2006 Oct | 17190098 |
| Recent developments in antithrombotic therapy: will sodium warfarin be a drug of the past? | Recent Pat Cardiovasc Drug Discov | 2006 Nov | 18221095 |
| Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemiaand bleeding. | Am J Ther | 2006 May-Jun | 16772772 |
| Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement. | J Cardiovasc Nurs | 2006 May-Jun | 16699355 |
| Warfarin and its interactions with foods, herbs and other dietary supplements. | Expert Opin Drug Saf | 2006 May | 16610971 |
| Antiinflammatory effect of Japanese horse chestnut (Aesculus turbinata) seeds. | J Vet Med Sci | 2006 May | 16757892 |
| Dietary vitamin K variability affects International Normalized Ratio (INR)coagulation indices. | Int J Vitam Nutr Res | 2006 Mar | 16941417 |
| A spectroscopic study of the interaction of isoflavones with human serum albumin. | FEBS J | 2006 Feb | 16420470 |
| Cranberry does not affect prothrombin time in male subjects on warfarin. | J Am Diet Assoc | 2006 Dec | 17126638 |